Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bu-Shen Hua-Yu granules (also known as Bushen Huayu granules or Bushen Huayu Recipe) is an investigational traditional Chinese medicine (TCM) formulation developed by Shanghai 6th People's Hospital. It is designed to tonify the kidney, resolve phlegm, remove blood stasis, and dredge collaterals. The formulation consists of six main herbal and animal-derived ingredients: *Cistanche deserticola* (Rou Cong-Rong), *Pheretima aspergillum* (Dilong), *Alpinia oxyphylla* (Yizhiren), *Salvia miltiorrhiza* (Danshen), *Radix Curcumae* (Yujin), and leech (Shuizhi). Bu-Shen Hua-Yu granules are being evaluated in clinical trials as an integrative traditional Chinese and Western medicine strategy to improve blood pressure variability, cognitive function, and arterial stiffness in patients with cerebral small vessel disease (CSVD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bu-Shen Hua-Yu granules.